Terms: = Germ cell tumor AND MYCN, N-myc, 4613, ENSG00000134323, NMYC, MODED, ODED AND Staging
161 results:
1. Analysis of the relationship between mycn gene and serum NSE and urinary VMA levels and neuroblastoma pathological features and prognosis.
Zhang H; He X; Miao Q; Li L; Song J; Jiang X
Cell Mol Biol (Noisy-le-grand); 2024 Apr; 70(4):134-139. PubMed ID: 38678619
[TBL] [Abstract] [Full Text] [Related]
2. Retinoblastoma and polydactyly in a child with 46, XY, 15pstk+ karyotype-A case report and literature review.
Pi X; Zhang Q; Wang X; Jiang F
Mol Genet Genomic Med; 2024 Mar; 12(3):e2414. PubMed ID: 38465842
[TBL] [Abstract] [Full Text] [Related]
3. Diagnostic Imaging for Retinoblastoma Cancer staging: Guide for Providing Essential Insights for Ophthalmologists and Oncologists.
Pai V; Muthusami P; Ertl-Wagner B; Shroff MM; Parra-Fariñas C; Sainani K; Kletke S; Brundler MA; Mallipatna A
Radiographics; 2024 Apr; 44(4):e230125. PubMed ID: 38451848
[TBL] [Abstract] [Full Text] [Related]
4. Histone Methyltransferases G9a/
Souza BK; Freire NH; Monteiro TS; Herlinger AL; Jaeger M; Dalmolin MGS; de Farias CB; Gregianin L; Brunetto AT; Brunetto AL; Thiele CJ; Roesler R
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894922
[TBL] [Abstract] [Full Text] [Related]
5. Posttreatment complications in pediatric cervical neuroblastoma: A retrospective case series at a tertiary cancer center.
Lopez J; Subramanian T; Durell J; Levyn H; Wong R; Shah J; LaQuaglia MP; Gerstle JT
J Surg Oncol; 2024 Feb; 129(2):219-223. PubMed ID: 37850570
[TBL] [Abstract] [Full Text] [Related]
6. Musashi-2 (MSI2) promotes neuroblastoma tumorigenesis through targeting MYC-mediated glucose-6-phosphate dehydrogenase (G6PD) transcriptional activation.
Jiang P; Zhang T; Wu B; Li X; Fu M; Xu B
Med Oncol; 2023 Oct; 40(11):332. PubMed ID: 37843625
[TBL] [Abstract] [Full Text] [Related]
7. Impact of BCL-2 Expression on Course of Disease in Neuroblastoma.
Muehling J; Fröba-Pohl A; Muensterer OJ; von Schweinitz D; Kappler R
Eur J Pediatr Surg; 2024 Feb; 34(1):69-77. PubMed ID: 37774735
[TBL] [Abstract] [Full Text] [Related]
8. Prognostic Value of Metabolic Parameters and Textural Features in Pretreatment
Wang G; Si Y; Liu J; Wang W; Yang J
Acad Radiol; 2024 Mar; 31(3):1091-1101. PubMed ID: 37748956
[TBL] [Abstract] [Full Text] [Related]
9. A novel clinical tool and risk stratification system for predicting the event-free survival of neuroblastoma patients: A TARGET-based study.
Li M; Duan X; Li C; You D; Liu L
Medicine (Baltimore); 2023 Sep; 102(38):e34925. PubMed ID: 37746942
[TBL] [Abstract] [Full Text] [Related]
10. Integration of clinical characteristics and molecular signatures of the tumor microenvironment to predict the prognosis of neuroblastoma.
Cheng H; Zhang L; Yang S; Ren Q; Chang S; Jin Y; Mou W; Qin H; Yang W; Zhang X; Zhang W; Wang H
J Mol Med (Berl); 2023 Nov; 101(11):1421-1436. PubMed ID: 37712965
[TBL] [Abstract] [Full Text] [Related]
11. Development and validation of a nomogram for predicting survival in intermediate- and high-risk neuroblastoma of the Children's Oncology Group risk stratification.
Feng L; Kan Y; Wang W; Wang C; Zhang H; Xie P; Yang J
J Cancer Res Clin Oncol; 2023 Dec; 149(18):16377-16390. PubMed ID: 37702807
[TBL] [Abstract] [Full Text] [Related]
12. Optimizing reirradiation for relapsed medulloblastoma: identifying the ideal patient and tumor profiles.
Massimino M; Vennarini S; Buttarelli FR; Antonelli M; Colombo F; Minasi S; Pecori E; Ferroli P; Giussani C; Schiariti M; Schiavello E; Biassoni V; Erbetta A; Chiapparini L; Nigro O; Boschetti L; Gianno F; Miele E; Modena P; De Cecco L; Pollo B; Barretta F
J Neurooncol; 2023 Jul; 163(3):577-586. PubMed ID: 37326761
[TBL] [Abstract] [Full Text] [Related]
13. Ganglioneuroblastoma intermixed: Clinicopathological implications of diagnosis at presentation and genomic correlations.
Nezami BG; Modak S; Cardenas FI; Sarungbam J; Sirintrapun SJ; Gopalan A; Chen Y; Al-Ahmadie H; Fine SW; Reuter VE; Tickoo SK
Pediatr Blood Cancer; 2023 Aug; 70(8):e30434. PubMed ID: 37243318
[TBL] [Abstract] [Full Text] [Related]
14. Survival of Patients With Neuroblastoma After Assignment to Reduced Therapy Because of the 12- to 18-Month Change in Age Cutoff in Children's Oncology Group Risk Stratification.
Bender HG; Irwin MS; Hogarty MD; Castleberry R; Maris JM; Kao PC; Zhang FF; Naranjo A; Cohn SL; London WB
J Clin Oncol; 2023 Jun; 41(17):3149-3159. PubMed ID: 37098238
[TBL] [Abstract] [Full Text] [Related]
15. Prognostic value of xenograft engraftment in patients with metastatic high-risk neuroblastoma.
Aschero R; Castillo-Ecija H; Baulenas-Farres M; Resa-Pares C; Jimenez-Cabaco A; Rodriguez E; Monterrubio C; Perez-Jaume S; Suñol M; Chantada GL; Lavarino C; Mora J; Carcaboso AM
Pediatr Blood Cancer; 2023 Jun; 70(6):e30318. PubMed ID: 36973999
[TBL] [Abstract] [Full Text] [Related]
16. ALK Gene Mutation and ALK Protein Expression in Advanced Neuroblastoma and the Potential Value in Risk Stratification in Fine-Needle Aspiration Biopsy Samples.
Bhardwaj N; Rohilla M; Gautam U; Trehan A; Bansal D; Kakkar N; Srinivasan R
Am J Clin Pathol; 2023 Apr; 159(4):407-415. PubMed ID: 36812383
[TBL] [Abstract] [Full Text] [Related]
17. Impact of Genomic and Clinical Factors on Outcome of Children ≥18 Months of Age with Stage 3 Neuroblastoma with Unfavorable Histology and without mycn Amplification: A Children's Oncology Group (COG) Report.
Pinto N; Naranjo A; Ding X; Zhang FF; Hibbitts E; Kennedy R; Tibbetts R; Wong-Michalak S; Craig DW; Manojlovic Z; Hogarty MD; Kreissman S; Bagatell R; Irwin MS; Park JR; Asgharzadeh S
Clin Cancer Res; 2023 Apr; 29(8):1546-1556. PubMed ID: 36749880
[TBL] [Abstract] [Full Text] [Related]
18. A Random Forest-based Classifier for mycn Status Prediction in Neuroblastoma using CT Images.
Pereira T; Silva F; Claro P; Carvalho DC; Dias SC; Torrao H; Oliveira HP
Annu Int Conf IEEE Eng Med Biol Soc; 2022 Jul; 2022():3854-3857. PubMed ID: 36086471
[TBL] [Abstract] [Full Text] [Related]
19. [Clinical characteristics and prognostic analyses of cervical neuroblastoma].
Liu QY; Wang SC; Jin YQ; Chu P; Guo YL; Ma XL; Su Y; Zhang J; Li YZ; Zhang XX; Sun N; Liu ZY; Ni X
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2022 Jun; 57(6):711-717. PubMed ID: 35725314
[No Abstract] [Full Text] [Related]
20. Neuroblastoma: Essential genetic pathways and current therapeutic options.
Salemi F; Alam W; Hassani MS; Hashemi SZ; Jafari AA; Mirmoeeni SMS; Arbab M; Mortazavizadeh SMR; Khan H
Eur J Pharmacol; 2022 Jul; 926():175030. PubMed ID: 35605657
[TBL] [Abstract] [Full Text] [Related]
[Next]
